Italia markets closed

BMY Nov 2025 57.500 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,65000,0000 (0,00%)
Alla chiusura: 12:48PM EDT
Schermo intero
Chiusura precedente1,6500
Aperto1,6500
Denaro1,7700
Lettera4,4500
Prezzo d'esercizio57,50
Scadenza2025-11-21
Min-Max giorno1,6500 - 1,6500
Contratto - Min-MaxN/D
Volume7
Open Interest232
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri